title: The role of the AMPA receptor and 5-HT(3) receptor on aggressive behavior and depressive-like symptoms in chronic social isolation-reared mice.
abstract: Chronic social isolation (SI)-reared mice exhibit aggressive and depressive-like behaviors. However, the pathophysiological changes caused by chronic SI remain unclear. The hypothalamus and amygdala have been suggested to be associated with the stress of SI. In addition to serotonin 3 (5-HT3) receptors, AMPA receptors have also been suggested to be involved in aggressive behavior and depressive-like symptoms in animals. Therefore, we examined whether chronic SI affects AMPA and 5-HT3 receptor expression levels in these regions. A Western blot analysis revealed that after four weeks of SI, mice exhibited up-regulated AMPA receptor subunit (GluR1, GluR2) protein levels in the amygdala and down-regulated hypothalamic 5-HT3 receptor protein levels. The AMPA/kainate receptor antagonist NBQX (10 mg/kg; i.p.) attenuated SI-induced depressive-like symptoms but not aggressive behavior. Intra-amygdalar infusions of the selective AMPA receptor agonist (S)-AMPA (10 μM) induced despair-like behavior, but not sucrose preference or aggressive behavior, in mice not reared in SI (naïve mice). Alternatively, treatment with the 5-HT3 receptor agonist SR57227A (3.0 mg/kg; i.p.) decreased aggression levels. In addition, intra-hypothalamic infusions of the 5-HT3 receptor antagonist ondansetron (3 μM) did not trigger aggressive behavior in naïve mice; however, the administration of ondansetron (0.3 mg/kg; i.p.) increased aggression levels in two-week SI mice, which rarely exhibited the aggressive behavior. Moreover, ondansetron did not affect the depressive-like symptoms of the SI mice. These results suggest that SI-induced up-regulation of GluR1 and GluR2 subunits protein levels in the amygdalar region and down-regulation of 5-HT3 receptor proteins level in the hypothalamic region are associated with the effect of AMPA receptor agonist and 5-HT3 receptor antagonist -induced aggressive behavior and depressive-like symptoms.
authors.affiliation: Department of Pharmacology, School of Pharmaceutical Science, Ohu University, 31-1 Misumido, Tomitamachi, Koriyama, Fukushima 963-8611, Japan.
authors.forename: Koh
authors.initials: K
authors.lastname: Shimizu
authors.affiliation: Department of Pharmacology, School of Pharmaceutical Science, Ohu University, 31-1 Misumido, Tomitamachi, Koriyama, Fukushima 963-8611, Japan.
authors.forename: Natsuki
authors.initials: N
authors.lastname: Kurosawa
authors.affiliation: Department of Pharmacology, School of Pharmaceutical Science, Ohu University, 31-1 Misumido, Tomitamachi, Koriyama, Fukushima 963-8611, Japan. Electronic address: k-seki@pha.ohu-u.ac.jp.
authors.forename: Kenjiro
authors.initials: K
authors.lastname: Seki
mesh_terms: D000374:Aggression / Q000187:drug effects / Q000502:physiology* / Q000523:psychology; D000679:Amygdala / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D003863:Depression / Q000188:drug therapy / Q000378:metabolism* / Q000523:psychology; D005518:Food Preferences / Q000187:drug effects / Q000502:physiology; D005968:Glutamate Decarboxylase / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D008845:Microinjections; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000378:metabolism; D017294:Ondansetron / Q000008:administration & dosage / Q000494:pharmacology; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology; D011810:Quinoxalines / Q000494:pharmacology / Q000627:therapeutic use; D018091:Receptors, AMPA / Q000819:agonists / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D044406:Receptors, Serotonin, 5-HT3 / Q000096:biosynthesis / Q000502:physiology*; D012934:Social Isolation / Q000523:psychology*; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / Q000008:administration & dosage / Q000819:agonists
chemical_list: D005968:Glutamate Decarboxylase; D017294:Ondansetron; D010880:Piperidines; D011810:Quinoxalines; D018091:Receptors, AMPA; D044406:Receptors, Serotonin, 5-HT3; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; C062865:2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline; C402565:glutamate decarboxylase 1; C401141:glutamate decarboxylase 2; C083009:4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride; C104722:glutamate receptor ionotropic, AMPA 2
keywords: 5-HT(3) receptor; AMPA receptor; Aggressive behavior; Amygdala; Depressive-like behavior; Social isolation